Dapsone (Taro Pharmaceuticals U.S.A., Inc.)
Welcome to the PulseAid listing for the Dapsone drug offered from Taro Pharmaceuticals U.S.A., Inc.. This Sulfone [EPC],Sulfones [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Taro Pharmaceuticals U.S.A., Inc. |
| NON-PROPRIETARY NAME: | Dapsone |
| SUBSTANCE NAME: | DAPSONE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Sulfone [EPC],Sulfones [Chemical/Ingredient] |
| ROUTE: | TOPICAL |
| DOSAGE FORM: | GEL |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2017-10-16 |
| END MARKETING DATE: | 0000-00-00 |
Dapsone HUMAN PRESCRIPTION DRUG Details:
| Item Description | Dapsone from Taro Pharmaceuticals U.S.A., Inc. |
| LABELER NAME: | Taro Pharmaceuticals U.S.A., Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 50(mg/g) |
| START MARKETING DATE: | 2017-10-16 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 51672-1387_3a9a1780-9004-41b6-bf7a-70567b663b9f |
| PRODUCT NDC: | 51672-1387 |
| APPLICATION NUMBER: | ANDA209506 |
Other DAPSONE Pharmaceutical Manufacturers / Labelers:
